Jane Street’s Lumos Pharma, Inc. Common Stock LUMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-1,753
Closed -$40K 6132
2019
Q4
$40K Buy
+1,753
New +$25K ﹤0.01% 4922
2019
Q3
Sell
-13,397
Closed -$178K 5901
2019
Q2
$178K Buy
+13,397
New +$202K ﹤0.01% 4720
2019
Q1
Sell
-1,353
Closed -$19K 5775
2018
Q4
$19K Buy
+1,353
New +$23.8K ﹤0.01% 4797
2018
Q2
Sell
-1,435
Closed -$94K 5753
2018
Q1
$94K Buy
+1,435
New +$102K ﹤0.01% 4613
2017
Q4
Sell
-1,887
Closed -$173K 5297
2017
Q3
$173K Sell
1,887
-475
-20% -$36.4K ﹤0.01% 4168
2017
Q2
$156K Buy
+2,362
New +$292K ﹤0.01% 4092
2016
Q2
Sell
-3,625
Closed -$449K 4705
2016
Q1
$594K Buy
3,625
+2,805
+342% +$569K ﹤0.01% 2413
2015
Q4
$268K Sell
820
-92
-10% -$29.9K ﹤0.01% 3240
2015
Q3
$294K Sell
912
-2,960
-76% -$1.3M ﹤0.01% 2817
2015
Q2
$1.54M Buy
3,872
+3,338
+625% +$1.42M 0.01% 1179
2015
Q1
$263K Buy
+534
New +$207K ﹤0.01% 2632
2014
Q1
Sell
-1,787
Closed -$354K 3139
2013
Q4
$354K Buy
+1,787
New +$318K 0.01% 1511
2013
Q3
Sell
-1,275
Closed -$226K 3207
2013
Q2
$226K Buy
+1,275
New +$181K ﹤0.01% 2146

Other funds holding LUMO

Jane Street's LUMO Position: Q1 2020 in Review

Jane Street sold out of Lumos Pharma, Inc. Common Stock (LUMO) in Q1 2020, closing a stake of 1,753 shares — an estimated $40K sold.

Jane Street first reported a position in LUMO in Q2 2013 and held it in 13 quarters. The position peaked at $1.54M in Q2 2015. 46 funds tracked by Wall St. Rank hold LUMO as of Q1 2020.

  • Jane Street reported no remaining Lumos Pharma, Inc. Common Stock position as of Q1 2020 after selling out during the quarter.
  • Jane Street sold 1,753 Lumos Pharma, Inc. Common Stock shares in Q1 2020, an estimated $40K.
  • Jane Street first reported a position in Lumos Pharma, Inc. Common Stock in Q2 2013 and held it in 13 quarters.
  • Jane Street's Lumos Pharma, Inc. Common Stock position peaked at $1.54M in Q2 2015.
  • 46 funds tracked by Wall St. Rank held Lumos Pharma, Inc. Common Stock as of Q1 2020.

Based on Jane Street's 13F filing for Q1 2020, filed 15 May 2020.